3DBio Therapeutics
Harlan F. Weisman, M.D., is the Executive Chairman of 3DBio Therapeutics. He was formerly the Chief Science and Technology Officer for Medical Devices and Diagnostics at Johnson & Johnson. Prior, Dr. Weisman held the position of Company Group Chairman, Research & Development for Pharmaceuticals. Dr. Weisman joined J&J from Centocor, where he was the President of Research & Development. Harlan was also an Assistant Professor of Medicine and Consultant Cardiologist at Johns Hopkins University School of Medicine. Dr. Weisman received his B.A. in Philosophy from the University of Maryland and his M.D. from the University of Maryland School of Medicine.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
3DBio Therapeutics
3DBio Therapeutics is a biologics and bioprinting company with a focus on regenerative medicine that precision manufactures living tissues to allow the replacement of each individual patient’s parts with tissues designed and created specifically for them. 3DBio has developed unique capabilities toward the creation of living tissue implants for therapeutic applications.